For the Inventor, By the Inventor

Enter assignee name

St. Louis, MO, United States of America

Confluence Life Sciences, Inc.

USPTO Granted Patents = 12

% Expired Patents = 58.3

CIPO Patents = 1

Forward Citations = 58

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Shaun Raj Selness (8 out of 32 patents)

Joseph B Monahan (8 out of 19 patents)

Susan Landis Hockerman (7 out of 32 patents)

4. Balekudru Devadas (7 out of 68 patents)

5. John F Schindler (5 out of 6 patents)

6. James Robert Blinn (4 out of 21 patents)

7. John Robert Springer (3 out of 12 patents)

8. Eric Jon Jacobsen (3 out of 46 patents)

9. Eric Jonathan Jacobsen (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 9695200 - Heterocyclic ITK inhibitors for treating inflammation and cancer (2017-07-04),

2. 9636333 - Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds (2017-05-02),

3. 9505765 - 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment (2016-11-29),

4. 9499551 - Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseases (2016-11-22),

5. 9365547 - Substituted pyridinone-pyridinyl compounds (2016-06-14),

6. 9365546 - Substituted pyridinone-pyridinyl compounds (2016-06-14),

7. 9359300 - Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds (2016-06-07),

8. 9145393 - Arylpyridinone ITK inhibitors for treating inflammation and cancer (2015-09-29),

9. 9115089 - Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds (2015-08-25),

10. 9056110 - Substituted pyrimidinone-phenyl-pyrimidinyl compounds (2015-06-16),

11. 8563558 - Substituted pyridine urea compounds (2013-10-22),

12. 8507499 - Substituted indole/indazole-pyrimidinyl compounds (2013-08-13),

Confluence Life Sciences, Inc. is a biotechnology company that specializes in the discovery and development of novel therapeutics. They focus on utilizing advanced technologies and scientific insights to address unmet medical needs. With a team of experienced researchers and a strong emphasis on innovation, Confluence Life Sciences strives to bring transformative solutions to patients and improve healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 8 2026

12 Patents

#161 in St. Louis, MO

#364 in Missouri

#25,482 in US

#48,001 in the World

St. Louis, MO, United States of America

Confluence Life Sciences, Inc.

Forward Citations = 58

9 inventors:

Shaun Raj Selness (8 out of 32 patents)

Joseph B Monahan (8 out of 19 patents)

Susan Landis Hockerman (7 out of 32 patents)

4. Balekudru Devadas (7 out of 68 patents)

5. John F Schindler (5 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…